Epidemiology of adult rheumatoid arthritis

Y Alamanos, AA Drosos - Autoimmunity reviews, 2005 - Elsevier
Several incidence and prevalence studies of rheumatoid arthritis (RA) have been reported
during the last decades, suggesting a considerable variation of the disease occurrence …

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review

Y Alamanos, PV Voulgari, AA Drosos - Seminars in arthritis and rheumatism, 2006 - Elsevier
OBJECTIVES: To conduct a systematic review of incidence and prevalence studies of
rheumatoid arthritis (RA), based on the 1987 revised American College of Rheumatology (ACR) …

Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982–2003

…, AI Venetsanopoulou, C Siozos, AA Drosos - …, 2006 - academic.oup.com
Objectives. To investigate the incidence and prevalence, as well as the mortality and survival
rates, of primary Sjögren's syndrome (pSS) in a defined area of north-west Greece with a …

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity …

…, L Czirják, A De Luca, AA Drosos… - Annals of the …, 2001 - ard.bmj.com
OBJECTIVE To develop criteria for disease activity in systemic sclerosis (SSc) that are valid,
reliable, and easy to use. METHODS Investigators from 19 European centres completed a …

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

…, S Braga, J Coll, SD Vita, AA Drosos… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. Different sets of diagnostic criteria have been proposed for Sjögren's syndrome (SS),
but none have been validated with a large series of patients or in a multicenter study. We …

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

…, S Vasakos, SN Nikas, AA Drosos - Annals of the …, 2005 - ard.bmj.com
Background: Tumour necrosis factor α (TNFα) may be an important mediator of insulin
resistance. Infliximab is a chimeric monoclonal, high affinity antibody against the soluble and …

[HTML][HTML] Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide

JPA Ioannidis, KA Boki, ME Katsorida, AA Drosos… - Kidney international, 2000 - Elsevier
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide.
Background Long-term intravenous cyclophosphamide (IVC) in combination with …

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database

…, K Immonen, JF Maillefert, AA Drosos… - Annals of the …, 2009 - ard.bmj.com
Objective: To analyse associations between the clinical status of patients with rheumatoid
arthritis (RA) and the gross domestic product (GDP) of their resident country. Methods: The …

Remission and rheumatoid arthritis: data on patients receiving usual care in twenty‐four countries

…, B Combe, H Badsha, AA Drosos… - Arthritis & …, 2008 - Wiley Online Library
Objective To compare the performance of different definitions of remission in a large
multinational cross‐sectional cohort of patients with rheumatoid arthritis (RA). Methods The …

Demyelination and other neurological adverse events after anti-TNF therapy

…, PV Voulgari, S Konitsiotis, AA Drosos - Autoimmunity reviews, 2014 - Elsevier
Tumor necrosis factor (TNF) α inhibitors are an essential therapeutic option for several
inflammatory diseases, like rheumatoid arthritis, spondyloarthropathies and inflammatory bowel …